Latest / Artificial Intelligence Exposed / How AI Are Redefining Healthcare

Transcript

How AI Are Redefining Healthcare · Artificial Intelligence Exposed

• 0:00
  Speaker 1: So back in twenty twenty, there was this AI algorithm
• 0:04
  Speaker 1: and it looked at a totally standard routine.
• 0:07
  Speaker 2: Chest X ray, right, just a regular scan, Yeah.
• 0:09
  Speaker 1: Exactly, just a normal scan. But it saw a pattern
• 0:13
  Speaker 1: that was so incredibly subtle, just completely buried in the
• 0:17
  Speaker 1: visual noise that literally not a single human eye on
• 0:20
  Speaker 1: the medical team could.
• 0:21
  Speaker 2: Even see it, which is just wild.
• 0:23
  Speaker 1: It is because okay, get this, five years later, that
• 0:26
  Speaker 1: exact same patient developed lung cancer in the exact microscopic
• 0:31
  Speaker 1: location that the AI had flagged.
• 0:32
  Speaker 2: Wow. I mean that really puts it in.
• 0:34
  Speaker 1: Perspective, right, I want you the listener to just imagine
• 0:36
  Speaker 1: that for a second. The machine didn't just see the
• 0:39
  Speaker 1: present state of the lungs. It essentially well, it saw
• 0:42
  Speaker 1: the future.
• 0:42
  Speaker 2: It did, and it forces us to completely, you know,
• 0:45
  Speaker 2: reevaluate what medicine actually is. Yeah, because for centuries, medicine
• 0:49
  Speaker 2: has been fundamentally reactive, right, I mean, a biological system breaks,
• 0:53
  Speaker 2: symptoms show up, and a human doctor tries to repair
• 0:56
  Speaker 2: the damage.
• 0:57
  Speaker 1: Like fixing a car after it breaks.
• 0:58
  Speaker 2: Down, exactly. But the source material we are examining today,
• 1:02
  Speaker 2: it outlines a totally different paradigm. We're talking about a
• 1:06
  Speaker 2: massive shift from traditional backward looking statistical models to these
• 1:13
  Speaker 2: highly sophisticated algorithms that are actually inspired by the human brain,
• 1:16
  Speaker 2: which is a huge leap. It's massive, and in doing so,
• 1:19
  Speaker 2: we are attempting to move the entire global healthcare apparatus
• 1:23
  Speaker 2: from reactive treatment to well proactive, predictive prevention.
• 1:29
  Speaker 1: And that is exactly our mission for today. We are
• 1:31
  Speaker 1: doing a DAP dive into the source material, specifically an
• 1:34
  Speaker 1: excerpt titled how Neural networks are Redefining Healthcare? Yes, and
• 1:38
  Speaker 1: our goal today is to really pull this thing apart.
• 1:41
  Speaker 1: We want to understand how these neural networks have trolled
• 1:43
  Speaker 1: out of the theoretical computer science labs and transformed into
• 1:47
  Speaker 1: honestly the most vital tools in modern medicines.
• 1:49
  Speaker 2: They really are disruptive in the best way.
• 1:51
  Speaker 1: Yeah, they're changing how we diagnose, how we treat, and
• 1:54
  Speaker 1: how we manage human health. But before we get into
• 1:57
  Speaker 1: the really wild applications, you know, like predicting all Olzheimer's
• 2:00
  Speaker 1: or a custom building drugs.
• 2:01
  Speaker 2: We have to lay the groundwork exactly.
• 2:04
  Speaker 1: We have to establish the baseline. We have to look
• 2:06
  Speaker 1: at the mechanics of how these systems actually differ from
• 2:09
  Speaker 1: the map that came before them. Yeah, because it's not
• 2:11
  Speaker 1: just you know, faster computers.
• 2:13
  Speaker 2: No, not at all. It's a completely different way of thinking,
• 2:15
  Speaker 2: and that distinction is just paramount. So let's look at
• 2:19
  Speaker 2: standard medical statistics, right, the absolute bedrock of twentieth century medicine.
• 2:24
  Speaker 2: When a traditional medical study evaluates a new treatment, or say,
• 2:29
  Speaker 2: tries to find a risk factor for a disease, it
• 2:31
  Speaker 2: relies on methods like linear regression or kaplan Meyer survival.
• 2:36
  Speaker 1: Curves, which sounds very technical.
• 2:38
  Speaker 2: It does, but essentially, researchers take a large population, they
• 2:42
  Speaker 2: isolate a few independent variables like age, blood pressure, smoking status,
• 2:47
  Speaker 2: and they draw a line of best fit to find
• 2:49
  Speaker 2: an average.
• 2:49
  Speaker 1: Okay, so it's all about finding the average.
• 2:52
  Speaker 2: You get a p value a hazard ratio. It's a
• 2:54
  Speaker 2: highly constrained linear way of looking at biology. It basically
• 2:58
  Speaker 2: assumes that if variable A goes up, variable B moves
• 3:02
  Speaker 2: in a predictable straight line response.
• 3:04
  Speaker 1: Which is a huge assumption when you are dealing with
• 3:07
  Speaker 1: something as incredibly complex as a human being. Right. I
• 3:11
  Speaker 1: mean that math essentially requires us to simplify the patient
• 3:15
  Speaker 1: just to make the equation work exactly.
• 3:17
  Speaker 2: You hit the nail on the head, and human biology
• 3:19
  Speaker 2: is fiercely nonlinear. Yeah, it's messy, super messy. Your blood
• 3:24
  Speaker 2: pressure doesn't just interact with your age, It interacts dynamically
• 3:27
  Speaker 2: with your sleep cycle, your genetic predispositions, your gut microbiomes,
• 3:30
  Speaker 2: stress levels at work, yes, stress, the micropollutants in your
• 3:34
  Speaker 2: local atmosphere. Everything. Traditional statistical models simply cannot handle that
• 3:39
  Speaker 2: level of multi variable codependence.
• 3:41
  Speaker 1: They just choke on the complexity.
• 3:42
  Speaker 2: They absolutely choke. But a neural network, which is structurally
• 3:46
  Speaker 2: inspired by the human brain, operates in a completely different
• 3:50
  Speaker 2: mathematical universe. Okay, how so, Well, it doesn't force a
• 3:53
  Speaker 2: straight line onto the data. It uses layers of artificial nodes,
• 3:57
  Speaker 2: often millions of them, that pass information forward, adjusting the
• 4:01
  Speaker 2: weights and biases of their connections through an optimization process
• 4:04
  Speaker 2: called back propagation.
• 4:05
  Speaker 1: Okay, wait, let's ground that a bit, because I really
• 4:07
  Speaker 1: want to make sure we don't lose the forest for
• 4:09
  Speaker 1: the trees here. Sure, if traditional statistics are like a
• 4:12
  Speaker 1: printed roadmap where you see the main highways, you calculate
• 4:15
  Speaker 1: the distance, and you get a general static idea of
• 4:18
  Speaker 1: how to get from point A to point B based
• 4:20
  Speaker 1: on historical averages.
• 4:22
  Speaker 2: I like this analogy.
• 4:23
  Speaker 1: Right, So if that's the map, then a neural network
• 4:26
  Speaker 1: is like a live, hyper connected GPS system calculating fluid dynamics. Yes,
• 4:31
  Speaker 1: it isn't just looking at the static piece of paper.
• 4:34
  Speaker 1: It's simultaneously tracking every single traffic jam, every pothole, every
• 4:39
  Speaker 1: localized weather event, the speed of every single car on
• 4:43
  Speaker 1: the road.
• 4:43
  Speaker 2: The exact timing of the traffic lights exactly.
• 4:46
  Speaker 1: All in real time, just to predict the exact minute
• 4:49
  Speaker 1: you will arrive. The paper map simply cannot hold that
• 4:52
  Speaker 1: many dimensions of data.
• 4:53
  Speaker 2: That is a phenomenal way to visualize it. The sheer
• 4:56
  Speaker 2: dimensionality of the data is the breakthrough here. Yeah, the
• 4:59
  Speaker 2: source material really emphasizes that these algorithms uncover highly complex
• 5:03
  Speaker 2: patterns to generate predictions that rival or even surpass human experts,
• 5:09
  Speaker 2: which is humbling, honestly, very but think about the cognitive
• 5:12
  Speaker 2: limits of a human physician. A brilliant doctor has a
• 5:16
  Speaker 2: vast repository of medical knowledge, sure, but their working memory
• 5:20
  Speaker 2: can only synthesize a handful of disparate facts at any
• 5:23
  Speaker 2: given moment. Right. They're only human, exactly. They cannot simultaneously
• 5:28
  Speaker 2: hold the minute variations of ten million patient histories in
• 5:31
  Speaker 2: their head. But a neural network operating in this high
• 5:35
  Speaker 2: dimensional vector space, it doesn't have a biological limit to
• 5:39
  Speaker 2: its working memory. It doesn't get tired never. It can
• 5:42
  Speaker 2: map thousands of variables simultaneously to find these invisible threads
• 5:46
  Speaker 2: connecting seemingly completely unrelated to data points.
• 5:50
  Speaker 1: Which fundamentally changes the value preposition of going to the
• 5:52
  Speaker 1: doctor in the first place. For you listening right now,
• 5:55
  Speaker 1: this means your medical care is evolving away from the
• 5:57
  Speaker 1: law of averages. Percisely, your treatment will just be based
• 6:00
  Speaker 1: on what happens to most people with your rough demographic profile.
• 6:05
  Speaker 1: It will be based on the exact, hyper specific mathematical
• 6:08
  Speaker 1: signature of your unique biology.
• 6:10
  Speaker 2: Which is incredible.
• 6:11
  Speaker 1: It is, And because these networks are so uniquely capable
• 6:15
  Speaker 1: of finding these complex, deeply buried patterns, their most immediate
• 6:19
  Speaker 1: and striking application has naturally emerged in the most pattern
• 6:23
  Speaker 1: heavy field of medicine, medical imaging. Yes, medical imaging, let's
• 6:27
  Speaker 1: get into that.
• 6:28
  Speaker 2: Absolutely. This brings us to the realm of deep convolutional
• 6:32
  Speaker 2: neural networks or CNNs CNN's The text specifically highlights how
• 6:37
  Speaker 2: these architectures are currently analyzing X rays MRIs and CT
• 6:41
  Speaker 2: scans with just astonishing precision. Right. To understand why CNNs
• 6:47
  Speaker 2: are so revolutionary for radiology, we really have to look
• 6:50
  Speaker 2: at how they process visual information. They don't just look
• 6:53
  Speaker 2: at an image the way you or I do. How
• 6:55
  Speaker 2: do they do it? They mathematically deconstruct it. A convolutional
• 6:58
  Speaker 2: neural network passes mathematical filters and call them kernels over
• 7:01
  Speaker 2: the pixel data of an image.
• 7:03
  Speaker 1: So it's kind of like sliding a tiny magnifying glass
• 7:05
  Speaker 1: over the picture, pixel by pixel.
• 7:07
  Speaker 2: Precisely like that. In the first layer, these filters might
• 7:10
  Speaker 2: just detect really simple edges, like where a light pixel
• 7:13
  Speaker 2: meets a dark pixel.
• 7:14
  Speaker 1: Okay, basic contrast, right, But as.
• 7:18
  Speaker 2: The data moves deeper into the network through all these
• 7:20
  Speaker 2: subsequent layers, these edges are combined into shapes. Then the
• 7:24
  Speaker 2: shapes are combined into textures, and the textures are combined
• 7:28
  Speaker 2: into complex anatomical structures, building it up piece by piece exactly.
• 7:33
  Speaker 2: The network basically creates a hierarchy of visual features. It
• 7:36
  Speaker 2: learns the mathematical signature of a perfectly healthy lung, and conversely,
• 7:41
  Speaker 2: it learns the microscopic mathematical signature of a malignant tumor
• 7:45
  Speaker 2: or even a tiny hairline microfracture.
• 7:47
  Speaker 1: But the scale of the learning, that's what really bends
• 7:50
  Speaker 1: the mind.
• 7:50
  Speaker 2: Here for me.
• 7:51
  Speaker 1: Oh absolutely, The text mentions training on millions of images.
• 7:55
  Speaker 1: Think about what it takes to become a master radiologist.
• 7:58
  Speaker 2: It's decades of work.
• 8:00
  Speaker 1: Right, you go to medical school, you do a gruelling residency,
• 8:02
  Speaker 1: you do a fellowship, over a thirty year career, working tirelessly.
• 8:06
  Speaker 1: A human radiologist might critically evaluate tens of thousands of.
• 8:10
  Speaker 2: Scans, a huge number for a human, right.
• 8:12
  Speaker 1: They build up this incredible human intuition and expert eye.
• 8:16
  Speaker 1: But the neural network, it analyzes millions of scans before
• 8:20
  Speaker 1: it is even deployed for its very first day of
• 8:23
  Speaker 1: clinical work. It really does.
• 8:24
  Speaker 2: It ingests thousands of human lifetimes of visual experience.
• 8:29
  Speaker 1: And it does so without fatigue, without the cognitive biases
• 8:33
  Speaker 1: of say the time of day, or without being distracted
• 8:36
  Speaker 1: by a pager going off in the hallway.
• 8:38
  Speaker 2: Right, it doesn't need a coffee break.
• 8:40
  Speaker 1: Exactly, But it is important to clarify how it actually
• 8:44
  Speaker 1: learns from those millions of images.
• 8:46
  Speaker 2: Yeah, break that down for us.
• 8:47
  Speaker 1: So during the training phase, the network makes a prediction,
• 8:50
  Speaker 1: it looks at a scan and says, okay, I think
• 8:53
  Speaker 1: this scan contains a tumor. If it is wrong, an
• 8:57
  Speaker 1: algorithm calculates the error okay, and then it propagates that
• 9:01
  Speaker 1: error backward through all those millions of connections, minutely adjusted
• 9:05
  Speaker 1: the mathematical weights of those filters, so that the next
• 9:08
  Speaker 1: time it sees a similar pattern, its prediction is just
• 9:11
  Speaker 1: slightly more accurate.
• 9:12
  Speaker 2: So it's learning from its mistakes, basically exactly.
• 9:15
  Speaker 1: Now, multiply that microscopic adjustment by millions of images and
• 9:18
  Speaker 1: billions of iterations, and you get a system that can
• 9:21
  Speaker 1: detect abnormalities that are quite literally invisible to the human eye. Okay,
• 9:25
  Speaker 1: but I have to push back a little on what
• 9:27
  Speaker 1: this actually means for the human being standing in the hospital. Sure,
• 9:31
  Speaker 1: because if the AI is achieving diagnostic accuracy equal to
• 9:36
  Speaker 1: or better then an experienced human radiologist, and the text
• 9:40
  Speaker 1: explicitly states it is doing that, are we reaching a
• 9:43
  Speaker 1: dangerous point of overreliance here?
• 9:46
  Speaker 2: That is a very valid concern.
• 9:48
  Speaker 1: Like if a doctor looks at a scan and sees
• 9:51
  Speaker 1: absolutely nothing, but the AI puts a big red bounding
• 9:54
  Speaker 1: box around a tiny cluster of pixels and says ninety
• 9:58
  Speaker 1: nine percent probability of malignancy. What does the doctor actually do, right?
• 10:02
  Speaker 1: Are we just rubber stamping the machine's homework at this
• 10:04
  Speaker 1: point because it feels like the human eye is becoming
• 10:06
  Speaker 1: completely secondary to the algorithm.
• 10:08
  Speaker 2: Well, that tension is very real, and it is a
• 10:10
  Speaker 2: massive topic of debate in medical informatics right now. However,
• 10:14
  Speaker 2: the paradigm shift the text describes isn't really about replacing
• 10:17
  Speaker 2: the radiologist's judgment.
• 10:18
  Speaker 1: What is it about, then?
• 10:20
  Speaker 2: It is about shifting the timeline of detection. You see,
• 10:23
  Speaker 2: the human eye has a physical limit regarding resolution and
• 10:26
  Speaker 2: contrast differentiation. By the time a cluster of malignant cells
• 10:31
  Speaker 2: is actually large enough and dense enough for a human
• 10:33
  Speaker 2: to definitively spot it on a standard scan, well, the
• 10:37
  Speaker 2: disease has often progressed significantly.
• 10:39
  Speaker 1: So it's already bad news by the time we see it.
• 10:42
  Speaker 2: Exactly. The neural network's ability to flag that microabnormality early
• 10:47
  Speaker 2: that is what matters. It's essentially a magnifying glass that
• 10:51
  Speaker 2: operates at the sub perceptual level. I see the machine
• 10:54
  Speaker 2: flags the anomaly, yes, but the human physician must still
• 10:58
  Speaker 2: synthesize that finding with the payation's history, their current physical state,
• 11:02
  Speaker 2: and their personal preferences to decide the actual clinical course
• 11:06
  Speaker 2: of action.
• 11:07
  Speaker 1: So it's kind of like the difference between spotting the
• 11:10
  Speaker 1: iceberg when it's still miles away versus spotting it when
• 11:13
  Speaker 1: it's already scraping the hull of your ship.
• 11:15
  Speaker 2: That is exactly it. It's buying time, and in oncology,
• 11:18
  Speaker 2: time is the single most valuable currency you have.
• 11:21
  Speaker 1: That makes total sense. But you know, seeing it tiny
• 11:23
  Speaker 1: tumor early on a scan is still fundamentally a reaction.
• 11:27
  Speaker 1: The tumor already exists the real leap And honestly, the
• 11:31
  Speaker 1: thing that I find absolutely fascinating the source material is
• 11:34
  Speaker 1: moving beyond the image entirely. Yes, the predictive models, right,
• 11:38
  Speaker 1: it's using neural networks as a predictive time machine. It's
• 11:42
  Speaker 1: not about finding the tumor, it's about predicting the tumor
• 11:45
  Speaker 1: before the very first cell even mutates.
• 11:47
  Speaker 2: And this is where we move from imaging data, which
• 11:50
  Speaker 2: is spatial, to longitudinal data, which is temporal. Okay, temporal
• 11:55
  Speaker 2: meaning over time exactly. The algorithms are now ingesting electronic
• 11:59
  Speaker 2: health record, full genetic sequences, and even lifestyle information. They
• 12:04
  Speaker 2: use all this to identify individuals at high risk for
• 12:07
  Speaker 2: diseases like Alzheimer's heart disease or diabetes, decades before any
• 12:11
  Speaker 2: symptoms ever appear. Decades, decades, And the mechanism here is
• 12:15
  Speaker 2: quite different from processing images. When an AI looks at
• 12:19
  Speaker 2: an electronic health record, it's often using architectures like recurrent
• 12:22
  Speaker 2: neural networks or RNNs, and increasingly transformers.
• 12:26
  Speaker 1: Wait, transformers like the same underlying architecture that powers large
• 12:30
  Speaker 1: language models like chat GPT.
• 12:32
  Speaker 2: Yes, exactly the same foundational structure.
• 12:34
  Speaker 1: Wait, hold on, you're saying, the AI treats my medical
• 12:37
  Speaker 1: history the same way a chatbot treats a paragraph of text.
• 12:41
  Speaker 2: How does that even work conceptually? Yes, it's fascinating. Think
• 12:44
  Speaker 2: of your medical history as a complex language. A symptom
• 12:47
  Speaker 2: you reported back in twenty eighteen that's a noun. A
• 12:50
  Speaker 2: blood test you took in twenty twenty that's a verb.
• 12:52
  Speaker 2: A prescription you filled last month that's an adjective.
• 12:55
  Speaker 1: Oh wow, I love it right now.
• 12:57
  Speaker 2: A human doctor looking at your file, they see disparate,
• 13:01
  Speaker 2: disconnected data points scattered across years. But a transformer model
• 13:05
  Speaker 2: can look at the entire sequence of your medical history simultaneous.
• 13:08
  Speaker 1: It reads the whole story.
• 13:09
  Speaker 2: Once it does, it understands the grammar and the syntax
• 13:13
  Speaker 2: of your health. Over time. It recognizes that a specific
• 13:16
  Speaker 2: sequence of minor, seemingly unrelated clinical events, say a slight
• 13:21
  Speaker 2: elevation in a specific enzyme, followed two years later by
• 13:24
  Speaker 2: a minor sleep disturbance, combined with a specific genetic marker,
• 13:28
  Speaker 2: all of that together creates a mathematical trajectory pointing straight
• 13:32
  Speaker 2: toward Alzheimer's disease.
• 13:33
  Speaker 1: I love that analogy so much as reading the grammar
• 13:36
  Speaker 1: of your biology.
• 13:37
  Speaker 2: It really is.
• 13:37
  Speaker 1: Think about traditional preventative medicine like a standard fire extinguisher. Okay,
• 13:41
  Speaker 1: you keep it on the wall, and when a fire
• 13:43
  Speaker 1: breaks out of your kitchen, you pull the pin, try
• 13:45
  Speaker 1: to put it out. Hopefully you catch it early. But
• 13:48
  Speaker 1: there is already smoke. There's already structural damage to the house.
• 13:52
  Speaker 2: Right, the damage is done exactly.
• 13:54
  Speaker 1: But what these sequential neural networks are doing is acting
• 13:57
  Speaker 1: like an incredibly advanced, totally omniscient smoke detector. Yeah, but
• 14:02
  Speaker 1: they aren't even waiting for the smoke.
• 14:04
  Speaker 2: No, they aren't.
• 14:05
  Speaker 1: They are analyzing the exact chemical composition of the air,
• 14:09
  Speaker 1: the humidity, the ambient temperature, the frayed wiring in the wall,
• 14:14
  Speaker 1: and the draft from the window, and they are calculating
• 14:17
  Speaker 1: that based on the complex interactions of all these invisible factors,
• 14:21
  Speaker 1: a spark is highly likely to occur next Tuesday at
• 14:24
  Speaker 1: four zero pm, which is just.
• 14:26
  Speaker 2: A brilliant way to put it, and that completely alters
• 14:29
  Speaker 2: the fundamental objective of healthcare. You are no longer managing symptoms.
• 14:33
  Speaker 2: You are intercepting trajectories.
• 14:35
  Speaker 1: Intercepting trajectories, I like that phrase.
• 14:37
  Speaker 2: When an algorithm can calculate a highly specific, multidimensional risk
• 14:42
  Speaker 2: profile for cardiovascular disease when you are only thirty five
• 14:46
  Speaker 2: years old. The clinical intervention isn't a bypass surgery later
• 14:50
  Speaker 2: in life. The intervention is highly targeted lifestyle modifications right now,
• 14:54
  Speaker 2: early stage pharmacological therapies, and continuous monitoring the threat before
• 15:01
  Speaker 2: the pathology ever physically materializes.
• 15:04
  Speaker 1: But you know, we have to pause and think about
• 15:06
  Speaker 1: the psychological weight of that for the patient. It's heavy,
• 15:09
  Speaker 1: It is incredibly heavy. Yeah. I want you, the person
• 15:11
  Speaker 1: listening right now, to imagine logging into your patient portal
• 15:15
  Speaker 1: on a Tuesday morning and seeing a dashboard that says
• 15:18
  Speaker 1: you have an eighty two percent statistical probability of developing
• 15:21
  Speaker 1: Alzheimer's in exactly twenty three years.
• 15:24
  Speaker 2: It's terrifying.
• 15:24
  Speaker 1: It's not just a vague, well your grandfather had it,
• 15:27
  Speaker 1: so keep an eye out kind of warning. It is
• 15:28
  Speaker 1: a precise data back timeline. How does that change your
• 15:33
  Speaker 1: life today? How does it change how you invest your money,
• 15:35
  Speaker 1: how you plan your career, how you look at your kids.
• 15:38
  Speaker 1: The psychological burden of perfect foresight is huge.
• 15:42
  Speaker 2: It really is a burden.
• 15:43
  Speaker 1: But from a purely biological standpoint, it is the holy grail.
• 15:48
  Speaker 1: It is ultimate prevention.
• 15:49
  Speaker 2: It is the holy grail, absolutely provided, of course, that
• 15:53
  Speaker 2: we actually have the tools to alter that timeline. Ah. Yes,
• 15:57
  Speaker 2: the catch, and this highlights a massive bottleneck in the
• 16:01
  Speaker 2: current medical ecosystem. If neural networks are going to predict
• 16:05
  Speaker 2: these diseases years or even decades in advance, we desperately
• 16:09
  Speaker 2: need the pharmacological tools ready to intercept.
• 16:11
  Speaker 1: Them, because what's the point of knowing if you can't
• 16:13
  Speaker 1: fix it?
• 16:14
  Speaker 2: Exactly? Telling someone they will get sick is clinically useless
• 16:18
  Speaker 2: if we don't have a drug to prevent it, which
• 16:20
  Speaker 2: leads directly to how neural networks are currently dismantling and
• 16:24
  Speaker 2: completely rebuilding the traditional pipeline of drug discovery.
• 16:27
  Speaker 1: And thank god they are, because the traditional pipeline is
• 16:30
  Speaker 1: an absolute nightmare of inefficiency.
• 16:32
  Speaker 2: Oh, it's incredibly slow.
• 16:33
  Speaker 1: The text reminds us that traditional drug discovery takes years,
• 16:36
  Speaker 1: usually way over a decade, and cost billions of dollars.
• 16:40
  Speaker 1: It is essentially a process of boot force, trial and error.
• 16:43
  Speaker 2: It really is. And to understand why it takes so long,
• 16:46
  Speaker 2: you have to understand the basic physics of pharmacology. Drug
• 16:49
  Speaker 2: discovery is often described using a lock and key metaphor.
• 16:52
  Speaker 2: I might have heard that the lock is a biological
• 16:56
  Speaker 2: target for example, maybe it's a malfunctioning protein on the
• 16:59
  Speaker 2: surface of a cancer cell or the spike protein of
• 17:02
  Speaker 2: a virus. Okay, and the key is a chemical compound
• 17:05
  Speaker 2: that can actually bind to that target and alter its function.
• 17:09
  Speaker 2: In the traditional high throughput screening model, pharmaceutical companies use
• 17:14
  Speaker 2: these massive robotic systems to physically test hundreds of thousands
• 17:18
  Speaker 2: of chemical compounds against the biological target in petrie dishes.
• 17:22
  Speaker 1: Physically testing them yeah, one by one.
• 17:24
  Speaker 2: Yes. It is a slow, incredibly expensive physical process of
• 17:29
  Speaker 2: checking every single key in the lock. And as you
• 17:32
  Speaker 2: might guess, most of the keys don't.
• 17:34
  Speaker 1: Fit right, And even if you do find a key
• 17:36
  Speaker 1: that happens to fit the lock in a Petrie dish,
• 17:39
  Speaker 1: you might find out five years later during a human
• 17:42
  Speaker 1: clinical trial that the key also happens to completely destroy the.
• 17:45
  Speaker 2: Patient's liver exactly. The failure rate in clinical trials is
• 17:49
  Speaker 2: just staggering because the physical screening process often completely fails
• 17:53
  Speaker 2: to account for the complex absorption, the distribution, the metabolism,
• 17:58
  Speaker 2: and the toxicity of the compound one it's inside a
• 18:00
  Speaker 2: living organism.
• 18:01
  Speaker 1: So how does AI fix this?
• 18:03
  Speaker 2: Well, what neural networks do is move this entire incredibly
• 18:07
  Speaker 2: slow physical process into a massive, high speed digital simulation.
• 18:12
  Speaker 1: Like the matrix for drugs.
• 18:13
  Speaker 2: Kind of instead of physically synthesizing the compounds in a lab,
• 18:18
  Speaker 2: AI architectures often specifically graph neural networks represent molecules mathematically.
• 18:24
  Speaker 2: They view a molecule as a graph where the atoms
• 18:28
  Speaker 2: are nodes and the chemical bonds are edges. They can
• 18:31
  Speaker 2: then computationally simulate exactly how the three dimensional structure of
• 18:35
  Speaker 2: that molecule will interact with the three dimensional structure of
• 18:37
  Speaker 2: the target protein.
• 18:38
  Speaker 1: They aren't just looking at the shape though, right, because
• 18:41
  Speaker 1: chemistry isn't just about shapes fitting together like lego bricks.
• 18:44
  Speaker 2: No, No, it is far more complex than simple geometry.
• 18:47
  Speaker 2: The neural networks simulates the quantum mechanics and the biophysics
• 18:50
  Speaker 2: of the interaction. It calculates the electrostatic repulsion, the vandervols forces,
• 18:55
  Speaker 2: the hydrogen bonding, and the thermodynamic free energy of the
• 18:59
  Speaker 2: entire bindar process. It searches through digital libraries containing billions
• 19:03
  Speaker 2: of hypothetical compounds, predicts exactly how they will fold and bind,
• 19:08
  Speaker 2: and identifies the handful of candidates that have the highest
• 19:10
  Speaker 2: probability of not only binding perfectly, but also actually surviving
• 19:15
  Speaker 2: the metabolic processes of the human body.
• 19:17
  Speaker 1: That is just it's mind blowing, and the source text
• 19:21
  Speaker 1: brings up the ultimate visceral proof of concept for this
• 19:25
  Speaker 1: that we all literally just lived through the COVID nineteen pandemic.
• 19:29
  Speaker 2: Yes, the perfect example.
• 19:30
  Speaker 1: When the virus hit, we didn't have ten years to
• 19:33
  Speaker 1: physically test compounds in a lab. Machine learning models were
• 19:36
  Speaker 1: deployed to rapidly evaluate existing drugs and novel compounds. It
• 19:40
  Speaker 1: was like taking the entire global pharmaceutical research pipeline and
• 19:44
  Speaker 1: just running it through a supercomputer on fast forward.
• 19:46
  Speaker 2: The pandemic provided the absolute validation for in silico drug discovery.
• 19:50
  Speaker 1: In silico meaning in the computer right.
• 19:53
  Speaker 2: By computationally narrowing down the vast chemical space, AI allowed
• 19:58
  Speaker 2: researchers to focus their physical lab resources on only the
• 20:01
  Speaker 2: most highly probable candidates, grastically compressing the timeline from foundational
• 20:06
  Speaker 2: research to clinical testing.
• 20:07
  Speaker 1: It saved years.
• 20:09
  Speaker 2: It did, and the text implies that while COVID nineteen
• 20:12
  Speaker 2: was the catalyst, this is now becoming the standard operating procedure.
• 20:16
  Speaker 2: We are entering an era where treatments for rare, previously
• 20:19
  Speaker 2: ignored diseases or rapid mutations of existing pathogens can be
• 20:24
  Speaker 2: mathematically designed and simulated in weeks rather than decades.
• 20:28
  Speaker 1: Okay, I see the absolute brilliance of the time and
• 20:30
  Speaker 1: money saved here. It's undeniable. But I have to play
• 20:35
  Speaker 1: Devil's advocate regarding safety. Of course, if an AI is
• 20:38
  Speaker 1: predicting these molecular interactions computationally and we are shading literally
• 20:42
  Speaker 1: years off the timeline, are we introducing a new kind
• 20:45
  Speaker 1: of risk? I mean it is speed fundamentally the enemy
• 20:47
  Speaker 1: of safety when it comes to injecting novel chemicals and
• 20:50
  Speaker 1: human bodies.
• 20:51
  Speaker 2: That is, a critical distinction that must be made really
• 20:53
  Speaker 2: clear here. The neural network is not independently approving drugs
• 20:56
  Speaker 2: for human consumption. Okay, good, Nor is it bypassing and
• 21:00
  Speaker 2: the rigorous safety protocols of human clinical trials. The time
• 21:04
  Speaker 2: saved is entirely in the discovery and the pre clinical phases, so.
• 21:08
  Speaker 1: It's just the initial sorting phase exactly.
• 21:10
  Speaker 2: It is eliminating the years previously wasted physically synthesizing and
• 21:14
  Speaker 2: testing chemical compounds that were mathematically doomed to fail anyway.
• 21:19
  Speaker 2: The AI essentially weeds out the thousands of failures in
• 21:22
  Speaker 2: the digital realm before they ever reach a physical lab.
• 21:25
  Speaker 2: I see. But the human researchers still take the AI's
• 21:28
  Speaker 2: top recommendations and put them through the exact same rigorous,
• 21:32
  Speaker 2: multi phase human clinical trials to ensure ultimate safety and efficacy.
• 21:37
  Speaker 2: The AI doesn't skip the safety checks. It just ensures
• 21:41
  Speaker 2: we only spend our time testing things that actually have
• 21:43
  Speaker 2: a real mathematical chance of working.
• 21:46
  Speaker 1: So it's filtering out the noise. Okay, that makes perfect sense.
• 21:48
  Speaker 1: So let's take a breath and look at where we are.
• 21:50
  Speaker 1: We have the CNN's reading the scans, we have the
• 21:52
  Speaker 1: sequence models, predicting the disease timeline decades out. We have
• 21:56
  Speaker 1: the graph neural networks computationally designing the exact drug to
• 22:00
  Speaker 1: intercept the disease. But how does all this immense population
• 22:04
  Speaker 1: level technological machinery actually apply to the individual person.
• 22:09
  Speaker 2: That's the next step.
• 22:10
  Speaker 1: The source material introduces this concept of the end of
• 22:13
  Speaker 1: one era, this whole idea of hyper personalization.
• 22:15
  Speaker 2: Yes, the n of one era. In clinical research, the
• 22:19
  Speaker 2: term n refers to the sample size of a trial,
• 22:21
  Speaker 2: so an end of one trials where the sample size
• 22:23
  Speaker 2: is exactly one individual you just you, just you. For
• 22:28
  Speaker 2: the past century, medicine has been forced to operate on
• 22:30
  Speaker 2: a population level. A drug gets approved because it works
• 22:34
  Speaker 2: for say, sixty percent of a test population.
• 22:37
  Speaker 1: Which sounds good on paper.
• 22:38
  Speaker 2: Sure, but if you fall into the forty percent where
• 22:41
  Speaker 2: it doesn't work, or even worse, where it causes severe
• 22:44
  Speaker 2: adverse reactions, the fact that it works for the average
• 22:46
  Speaker 2: person is completely irrelevant to you.
• 22:48
  Speaker 1: Right, It doesn't help me if I'm in the forty
• 22:50
  Speaker 1: percent exactly.
• 22:52
  Speaker 2: Neural networks are dismantling this broad brush approach by integrating
• 22:57
  Speaker 2: your specific genomics, your metabolic profile, your unique medical history,
• 23:02
  Speaker 2: and your real time physiological data to architect completely individualized therapies.
• 23:07
  Speaker 1: It's the difference between buying a suit off the rack
• 23:10
  Speaker 1: at a standard department store versus flying to sowl Row
• 23:14
  Speaker 1: to have a master tailor build a bespoke suit to
• 23:17
  Speaker 1: your exact measurements.
• 23:18
  Speaker 2: I love that comparison.
• 23:19
  Speaker 1: Because standard medicine is very off the rack. You know,
• 23:21
  Speaker 1: you get diagnosed with depression and the doctor prescribes the
• 23:24
  Speaker 1: standard first line SSRI that works for most people. You
• 23:27
  Speaker 1: take it, You wait six weeks, you hope the side
• 23:29
  Speaker 1: effects aren't too brutal, and you see if it fits.
• 23:31
  Speaker 1: If it doesn't, you go back and they try the
• 23:33
  Speaker 1: next one down the list. It's essentially trial and error
• 23:35
  Speaker 1: on your actual brain chemistry. It is. But neural networks
• 23:39
  Speaker 1: allow medicine to be that bespoke, custom tailored garment, designed
• 23:43
  Speaker 1: from the ground up for your specific cellular mechanics.
• 23:46
  Speaker 2: And nowhere is this more urgently needed or honestly more
• 23:49
  Speaker 2: effectively deployed right now than in oncology, which the text
• 23:54
  Speaker 2: explicitly highlights.
• 23:55
  Speaker 1: Cancer treatment.
• 23:57
  Speaker 2: Yes, cancer is fundamentally a disease of the genome. It
• 24:01
  Speaker 2: is a corruption of DNA. Historically, we treated cancer based
• 24:06
  Speaker 2: on its geographic location in the body, lung cancer, breast cancer,
• 24:09
  Speaker 2: colon cancer, using broad sectrum chemotherapy to essentially carpet bomb,
• 24:14
  Speaker 2: they're rapidly dividing cells just nuke the whole site from
• 24:17
  Speaker 2: morbit pretty much. But breast cancer in one patient can
• 24:21
  Speaker 2: be genetically completely different from breast cancer and another patient.
• 24:25
  Speaker 2: So what the neural networks do is analyze the multiomic
• 24:28
  Speaker 2: data of the tumor, the specific DNA mutations, the RNA expression,
• 24:33
  Speaker 2: the protein levels. They build a highly specific profile of
• 24:36
  Speaker 2: that exact tumor's vulnerabilities, finding the weak spot exactly, and
• 24:39
  Speaker 2: then they map those specific vulnerabilities against millions of potential
• 24:43
  Speaker 2: targeted therapies to find the exact molecular sniper rifle needed
• 24:47
  Speaker 2: to dismantle that specific cancer.
• 24:49
  Speaker 1: And the beauty of the sniper rifle versus the carpet
• 24:51
  Speaker 1: bomb is that you actually spare the healthy tissue.
• 24:53
  Speaker 2: That is a massive part of it.
• 24:55
  Speaker 1: The text specifically points out that this dual benefit not
• 24:58
  Speaker 1: only improve survival rate, but it dramtically minimizes unnecessary side effects.
• 25:04
  Speaker 1: You don't have to poison the patient to the brink
• 25:06
  Speaker 1: of death to kill the cancer if you know the
• 25:09
  Speaker 1: exact biochemical password to shut the tumor down precisely.
• 25:13
  Speaker 2: You maximize efficacy while minimizing toxicity. But to achieve this
• 25:17
  Speaker 2: level of hyper personalized, dynamic n of one medicine, the
• 25:22
  Speaker 2: neural network cannot just rely on static data.
• 25:25
  Speaker 1: It needs more than just a file.
• 25:26
  Speaker 2: It needs a constant, uninterrupted stream of telemetry from your body.
• 25:30
  Speaker 2: You cannot personalize a treatment algorithm in real time if
• 25:33
  Speaker 2: the system only receives an update on your physical condition
• 25:37
  Speaker 2: during a fifteen minute clinical visit once a year.
• 25:39
  Speaker 1: Right.
• 25:39
  Speaker 2: The algorithms require continuous data flow, which necessitates moving the
• 25:43
  Speaker 2: sensory apparatus out of the hospital and directly onto your body, which.
• 25:46
  Speaker 1: Brings us to the hardware. The source material really dels
• 25:49
  Speaker 1: into wearable devices and remote sensors. Yes, the wearables, and
• 25:53
  Speaker 1: we aren't talking about the clunky, awful heart monitors of
• 25:57
  Speaker 1: the nineteen nineties. We were talking about the smart watches,
• 26:00
  Speaker 1: the biometric rings, the continuous glucose monitors that millions of
• 26:04
  Speaker 1: people are wearing right now.
• 26:05
  Speaker 2: They've come a long way.
• 26:06
  Speaker 1: They have. They have evolved from novelty fitness trackers into
• 26:09
  Speaker 1: continuous data nodes. They are tracking heart read variability blood,
• 26:13
  Speaker 1: oxygen saturation, galvanic skin response, sleep staging, and respiration rates
• 26:19
  Speaker 1: continuously twenty four hours a.
• 26:22
  Speaker 2: Day, and the mathematical significance of continuous monitoring versus discrete
• 26:26
  Speaker 2: sampling just cannot be overstated. Think about the old concept
• 26:30
  Speaker 2: of episodic care. Okay, you go to the doctor once
• 26:33
  Speaker 2: a year, They wrap a cuff around your arm, they
• 26:35
  Speaker 2: take your blood pressure, and that single isolated number is
• 26:38
  Speaker 2: recorded in your chart as your baseline.
• 26:40
  Speaker 1: Your one data point for the year.
• 26:42
  Speaker 2: Right, But from a data science perspective, that single sample
• 26:46
  Speaker 2: is wildly, hopelessly flawed. Blood Pressure is highly volatile. It
• 26:50
  Speaker 2: fluctuates based on your hydration, how much you slept the
• 26:53
  Speaker 2: night before, your caffeine intake, or even just the anxiety
• 26:56
  Speaker 2: of sitting in the doctor's office, the classic white coat syndrome. Right.
• 27:00
  Speaker 1: Trying to understand the complex dynamic system of a human
• 27:04
  Speaker 1: body based on one single blood pressure reading a year,
• 27:08
  Speaker 1: it's like trying to understand the entire plot, the character arcs,
• 27:11
  Speaker 1: and the emotional depth of a three hour movie by
• 27:14
  Speaker 1: looking at one randomly selected still frame.
• 27:16
  Speaker 2: That is exactly what it is like.
• 27:18
  Speaker 1: You miss all the context, you miss the.
• 27:20
  Speaker 2: Trajectory, you violate the fundamental principles of signal processing. Conceptually,
• 27:25
  Speaker 2: going back to Niquist Shannon principles, if you don't sample
• 27:29
  Speaker 2: a dynamic system frequently enough, you completely miss the high
• 27:32
  Speaker 2: frequency anomalies.
• 27:33
  Speaker 1: You miss the important stuff right.
• 27:35
  Speaker 2: Continuous monitoring provides the entire film. The wearables capture thousands
• 27:39
  Speaker 2: of data points a day, and then the neural networks
• 27:42
  Speaker 2: utilize anomaly detection algorithms, often using structures like auto encoders
• 27:46
  Speaker 2: to learn the complex, multi dimensional manifold of what is
• 27:49
  Speaker 2: normal specifically for you, establishing the baseline exactly. And once
• 27:54
  Speaker 2: it establishes your deeply personalized baseline, it just monitors for
• 27:58
  Speaker 2: microscopic deviations.
• 27:59
  Speaker 1: So what happens when it finds one.
• 28:01
  Speaker 2: Well, if your resting heart rate elevates slightly and that's
• 28:03
  Speaker 2: combined with a minute drop in heart rate variability and
• 28:07
  Speaker 2: a fractional increase in body temperature while you sleep, the
• 28:09
  Speaker 2: algorithm can flag that your body is fighting a systemic
• 28:12
  Speaker 2: infection days before you even feel the first tickle in
• 28:16
  Speaker 2: your throat.
• 28:16
  Speaker 1: It transforms you from a passive patient into an active
• 28:20
  Speaker 1: continuous data node, feeding directly into a predictive health ecosystem,
• 28:26
  Speaker 1: which honestly sounds like a science fiction.
• 28:28
  Speaker 2: Utopia, right.
• 28:29
  Speaker 1: It does sound pretty perfect, a world where your watch
• 28:32
  Speaker 1: catches the anomaly, the AI predicts the pathogen, and a
• 28:35
  Speaker 1: bespoke treatment is synthesized before you even know you are sick.
• 28:39
  Speaker 1: But and this is a massive butt the source material
• 28:42
  Speaker 1: forces us to pump the brakes here. We have to
• 28:45
  Speaker 1: because building this utopian health ecosystem requires navigating some of
• 28:49
  Speaker 1: the most complex structural and operational landlines in modern technology.
• 28:53
  Speaker 2: Yes, the text is very clear that this integration is
• 28:56
  Speaker 2: absolutely fraught with friction. Segmenting out the challenges, the first
• 29:00
  Speaker 2: one is obviously data privacy and security.
• 29:02
  Speaker 1: It's the elephant in the room.
• 29:03
  Speaker 2: It is. The system we just described requires centralizing and
• 29:08
  Speaker 2: analyzing the most deeply sensitive intimate information a human being
• 29:12
  Speaker 2: can possibly generate, your genomic code, your continuous physiological telemetry,
• 29:18
  Speaker 2: your predicted risk for degenerative mental.
• 29:20
  Speaker 1: Diseases, all in one place.
• 29:22
  Speaker 2: Right. Aggregating that data into centralized cloud architectures creates an
• 29:26
  Speaker 2: incredibly lucrative, high value target for state sponsored cyber attacks
• 29:31
  Speaker 2: or massive corporate breaches.
• 29:33
  Speaker 1: It's a gold mine for hackers.
• 29:34
  Speaker 2: A literal gold mine. The infrastructure requires advancements in privacy
• 29:39
  Speaker 2: preserving AI things like federated learning.
• 29:41
  Speaker 1: What's federated learning?
• 29:43
  Speaker 2: That's where the model actually trains locally on your device,
• 29:45
  Speaker 2: like on your phone or your watch, without ever transmitting
• 29:48
  Speaker 2: your raw personal data to a central server. Only the
• 29:51
  Speaker 2: mathematical learnings are shared, not the personal data itself.
• 29:54
  Speaker 1: Okay, so that's a potential fix. But even if we
• 29:57
  Speaker 1: solve the security, even as if the data is perfectly
• 29:59
  Speaker 1: locked down, we still have to deal with the quality
• 30:02
  Speaker 1: of the data itself. And the text points directly to
• 30:05
  Speaker 1: the massive issue of bias in the training data leading
• 30:08
  Speaker 1: to unequal treatment.
• 30:09
  Speaker 2: And this is purely a mathematical reality of machine learning.
• 30:13
  Speaker 2: An algorithm is only as objective as the distribution of
• 30:16
  Speaker 2: the data it is trained on. Right. If you train
• 30:18
  Speaker 2: a highly sophisticated neural network to detect melanoma, for example,
• 30:23
  Speaker 2: but the database of images you use contains ninety five
• 30:25
  Speaker 2: percent light skin patients and only five percent dark skin patients, well,
• 30:29
  Speaker 2: the mathematical optimization process will naturally become highly accurate for
• 30:33
  Speaker 2: light skin and dangerously inaccurate for dark skin.
• 30:37
  Speaker 1: So it's not that the AI is consciously prejudiced, right,
• 30:39
  Speaker 1: It's just relentlessly optimizing for the majority data it was
• 30:43
  Speaker 1: fed exactly.
• 30:45
  Speaker 2: It is a failure of representation in the high dimensional space.
• 30:48
  Speaker 2: The model finds the mathematical minima for the data it
• 30:51
  Speaker 2: actually sees, and it remains entirely ignorant of the biological
• 30:54
  Speaker 2: variations it was never shown. That's scary. It is if
• 30:57
  Speaker 2: historical medical data contains systema disparities regarding who had access
• 31:02
  Speaker 2: to cutting edge diagnostics, the AI will internalize those disparities,
• 31:06
  Speaker 2: it will encode them into its predictive weights, and it
• 31:08
  Speaker 2: will confidently output unequal flawed medical advice under the powerful,
• 31:13
  Speaker 2: trusted guise of objective algorithmic analysis.
• 31:16
  Speaker 1: Which is why the source material insists that rigorous, continuous
• 31:20
  Speaker 1: validation against highly diverse data sets is totally.
• 31:24
  Speaker 2: Non negotiable, non negotiable, absolutely, and the.
• 31:26
  Speaker 1: Bias problem is deeply compounded by what I think is
• 31:30
  Speaker 1: honestly the most terrifying phrase in the entire excerpt, the
• 31:34
  Speaker 1: black box.
• 31:35
  Speaker 2: Ah, Yes, the black box.
• 31:36
  Speaker 1: Let's really break down the mechanics of the black box,
• 31:38
  Speaker 1: because it goes against everything we expect from modern science.
• 31:41
  Speaker 1: The text says it is difficult for clinicians to actually
• 31:44
  Speaker 1: understand how decisions are made by the AI. Why is that?
• 31:47
  Speaker 1: Why can't we just look at the code and see
• 31:48
  Speaker 1: the logic?
• 31:49
  Speaker 2: Well, because a modern deep neural network isn't coded in
• 31:52
  Speaker 2: the traditional sense. What do you mean a software engineer
• 31:55
  Speaker 2: didn't write a sequence of human readable if then statements.
• 31:59
  Speaker 2: The network learned by mathematically adjusting millions or even billions
• 32:03
  Speaker 2: of internal parameters across hundreds of hidden layers. Okay, When
• 32:07
  Speaker 2: it analyzes a patient, it is mapping their data into
• 32:10
  Speaker 2: a multidimensional vector space, perhaps a ten thousand dimensional space.
• 32:15
  Speaker 2: It draws complex nonlinear hyperplanes through that space to separate
• 32:19
  Speaker 2: the sick from the healthy. Okay, I'm trying to picture that.
• 32:22
  Speaker 2: You can. A human brain literally cannot visualize or comprehend
• 32:26
  Speaker 2: a ten thousand dimensional space. So when you input the data,
• 32:30
  Speaker 2: the network confidently outputs a diagnosis. But if you ask
• 32:34
  Speaker 2: the network show your work, which specific variables caused you
• 32:38
  Speaker 2: to make this decision, the sheer mathematical complexity of those
• 32:42
  Speaker 2: billions of interconnected weights obscures the path.
• 32:47
  Speaker 1: The internal logic is a black box. It is a
• 32:49
  Speaker 1: black box, and that creates a massive crisis of trust
• 32:52
  Speaker 1: at the clinical level. I mean, imagine being the doctor
• 32:54
  Speaker 1: in the room. The AI analyzes a patient's continuous data
• 32:57
  Speaker 1: and outputs of immediate intervention required administer highly toxic aggressive chemotherapy.
• 33:03
  Speaker 1: The doctor looks at the patient, looks at the AI
• 33:06
  Speaker 1: and realizes they cannot verify the math. Should the doctor
• 33:09
  Speaker 1: blindly trust an algorithm over their own decade of medical training.
• 33:13
  Speaker 2: It's an impossible situation.
• 33:14
  Speaker 1: If the patient asks, doctor, why are we doing this
• 33:17
  Speaker 1: extreme treatment? How does a physician ethically respond? Did they
• 33:21
  Speaker 1: just say, I don't know, the computer in the cloud
• 33:23
  Speaker 1: told me to and.
• 33:24
  Speaker 2: You have just articulated the exact bottleneck preventing widespread clinical
• 33:28
  Speaker 2: deployment Today in the practice of medicine, accountability is absolute right.
• 33:33
  Speaker 2: Someone has to be responsible if an error is made.
• 33:36
  Speaker 2: The medical community must be able to perform a root
• 33:38
  Speaker 2: cause analysis to understand why it happens so the protocol
• 33:41
  Speaker 2: can be changed. You cannot depose a multi dimensional latent
• 33:45
  Speaker 2: space in a medical malpractice lawsuit.
• 33:48
  Speaker 1: No, you can't put an algorithm on the witness steanh exactly.
• 33:51
  Speaker 2: This is why the text emphasizes the critical development of
• 33:54
  Speaker 2: explainable AI or XAI.
• 33:56
  Speaker 1: Explainable AI.
• 33:57
  Speaker 2: How does that work? Explainable AI and falls secondary algorithms
• 34:01
  Speaker 2: using techniques like sashap values or saliency maps that attempt
• 34:05
  Speaker 2: to reverse engineer the black box. They create localized, simplified
• 34:10
  Speaker 2: approximations of the AI's decision boundary. They highlight exactly which
• 34:14
  Speaker 2: pixels in the scan or which specific historical blood tests
• 34:18
  Speaker 2: most heavily influence the AI's final output.
• 34:21
  Speaker 1: So it's an attempt to force the black box to
• 34:23
  Speaker 1: provide a human readable.
• 34:24
  Speaker 2: Rationale, exactly to shine a light inside the box.
• 34:27
  Speaker 1: Okay, So we need federated learning to secure the privacy,
• 34:32
  Speaker 1: we need massive data diversification to fix the bias, and
• 34:35
  Speaker 1: we need explainable AI to pry open the black box,
• 34:39
  Speaker 1: so doctors aren't flying completely blind.
• 34:41
  Speaker 2: That's the checklist, and.
• 34:43
  Speaker 1: If we can navigate those massive technological hurdles. The final
• 34:47
  Speaker 1: section of our source material brings the entire narrative full circle.
• 34:51
  Speaker 1: It answers the ultimate question about the human being wearing
• 34:54
  Speaker 1: the white coat. Yes, the doctor's role, because despite the
• 34:57
  Speaker 1: AI doing the predicting and the analyzing and the drug designing,
• 35:01
  Speaker 1: the human doctors are not being automated out of existence.
• 35:03
  Speaker 1: Their job description is just undergoing a profound evolution.
• 35:07
  Speaker 2: The source text is very explicit about this. Neural networks
• 35:09
  Speaker 2: are augmenting healthcare professionals, not replacing them. Augment yes by
• 35:14
  Speaker 2: taking on the immense computational burden of routine large scale
• 35:18
  Speaker 2: data analysis. By acting as the tireless entity that can
• 35:23
  Speaker 2: read ten million MRI scans in an afternoon, screen a
• 35:27
  Speaker 2: billion chemical compounds for binding authiety, and continuously monitor the
• 35:31
  Speaker 2: real time telemetry of one hundred thousand patients simultaneously, the
• 35:36
  Speaker 2: systems liberate the clinician from the role of a data processor.
• 35:39
  Speaker 1: They don't have to be calculators anymore.
• 35:41
  Speaker 2: Exactly. The technology absorbs the mathematical heavy lifting.
• 35:45
  Speaker 1: It essentially transforms the AI into the ultimate omniscient clinical assistant.
• 35:49
  Speaker 1: It crunches the high dimensional data, reads every published medical
• 35:53
  Speaker 1: journal in seconds, identifies the invisible historical trajectories, and presents
• 35:58
  Speaker 1: the highly probable solutions on the back. And it does
• 36:00
  Speaker 1: all of this incredible computational labor precisely so the doctor
• 36:04
  Speaker 1: can actually sit down, look you in the eye, read
• 36:07
  Speaker 1: your body language, and help you navigate a deeply difficult,
• 36:10
  Speaker 1: deeply human choice.
• 36:12
  Speaker 2: Because medicine is not merely the application of biology, right
• 36:15
  Speaker 2: it is the application of science to the human condition.
• 36:18
  Speaker 2: That's a great way to put it. An algorithm can
• 36:20
  Speaker 2: calculate the exact statistical probability of a surgical procedure's success,
• 36:25
  Speaker 2: but an algorithm cannot sit with a family, assess their
• 36:28
  Speaker 2: emotional resilience, understand their cultural values, and navigate the profound
• 36:32
  Speaker 2: ambiguity of deciding whether a marginal increase in lifespan is
• 36:35
  Speaker 2: actually worth a significant decrease in the quality of that life.
• 36:39
  Speaker 2: Empathy basically yes, Empathy, empathy, ethical judgment, and complex context
• 36:44
  Speaker 2: aware decision making exists completely outside the bounds of mathematical optimization.
• 36:50
  Speaker 2: The source text notes that hospitals, technology conglomerates, and regulatory
• 36:54
  Speaker 2: bodies are investing heavily right now to build the safety
• 36:57
  Speaker 2: frameworks required to merge the computational supremacy of the AI
• 37:02
  Speaker 2: with the irreplaceable empathy of the physician.
• 37:05
  Speaker 1: It really is the dawn of a completely new era
• 37:07
  Speaker 1: of human health. Let's take a moment to look back
• 37:09
  Speaker 1: at the incredible scope of what we've covered today.
• 37:11
  Speaker 2: We covered a lot of ground we did.
• 37:14
  Speaker 1: We started by unpacking the deep mathematical shift from the
• 37:17
  Speaker 1: linear constraints of traditional statistics to the multidimensional vector spaces
• 37:21
  Speaker 1: of brain inspired neural networks. We explored how deep convolutional
• 37:25
  Speaker 1: networks use backpropagation in feature maps to see the invisible,
• 37:30
  Speaker 1: detecting the microscopic precursors of cancer in medical imaging.
• 37:34
  Speaker 2: And we analyzed how sequence models like transformers are treating
• 37:37
  Speaker 2: medical histories as a complex language, predicting the trajectory of
• 37:40
  Speaker 2: diseases like Alzheimer's years or even decades before symptom onset right.
• 37:44
  Speaker 1: And we broke down the physics of molecular simulation, showing
• 37:47
  Speaker 1: how AI bypasses the sluggish physical trial and error of
• 37:51
  Speaker 1: drug discovery to computationally designed perfect biological keys.
• 37:56
  Speaker 2: We dove into the end of one era, where broad
• 37:58
  Speaker 2: spectrum treatments are being replaced by bespoke multiomic therapies targeted
• 38:02
  Speaker 2: at your exact cellular mechanics.
• 38:04
  Speaker 1: We discussed the principles of continuous monitoring, exploring how the
• 38:08
  Speaker 1: wearable on your wrist establishes a continuous, high frequency baseline
• 38:12
  Speaker 1: to detect anomalies before you even feel sick. And importantly,
• 38:16
  Speaker 1: we confronted the harsh, complex realities of the system, the
• 38:20
  Speaker 1: imperative for federated privacy, the mathematical trap of biased training distributions,
• 38:26
  Speaker 1: and the absolute necessity of explainable AI to pierce the
• 38:30
  Speaker 1: opacity of the black box, all of.
• 38:32
  Speaker 2: Which points to a future where human clinicians are freed
• 38:35
  Speaker 2: from computational drudgery to focus entirely on human.
• 38:38
  Speaker 1: Empathy inspiring vision.
• 38:40
  Speaker 2: It is, but as we conclude this deep dive into
• 38:43
  Speaker 2: the source material, there is a profound, underlying philosophical implication
• 38:47
  Speaker 2: in all of this that I want to leave you with.
• 38:48
  Speaker 1: Okay, let's hear it.
• 38:49
  Speaker 2: We have discussed how these systems are shifting the entire
• 38:52
  Speaker 2: foundation of medicine from treating the sick to predicting and
• 38:56
  Speaker 2: preventing sickness.
• 38:57
  Speaker 1: Right the proactive paradigm.
• 38:59
  Speaker 2: But if these can ttinuous monitoring systems and predictive neural
• 39:02
  Speaker 2: networks actually achieve their ultimate goal, if they intercept every
• 39:07
  Speaker 2: single trajectory, modify every lifestyle, and computationally design every preventative drug,
• 39:13
  Speaker 2: ensuring you never actually manifest a disease, how does that
• 39:17
  Speaker 2: change our definition of what it means to be a patient.
• 39:20
  Speaker 2: If you are never technically sick, but you are continuously monitored,
• 39:24
  Speaker 2: continually analyzed, and perpetually treated to prevent a future pathology,
• 39:28
  Speaker 2: does the concept of a healthy person cease to exist.
• 39:31
  Speaker 2: Are we all just patients in a permanent, lifelong state
• 39:35
  Speaker 2: of prevention? Wow?
• 39:37
  Speaker 1: That is a staggering, fascinating thought to sit with as
• 39:40
  Speaker 1: we look toward this new frontier. The machine may solve
• 39:43
  Speaker 1: the math of our biology, but we still have to
• 39:45
  Speaker 1: figure out how to actually live with the answers. Thank
• 39:48
  Speaker 1: you so much for joining us as we tore this
• 39:49
  Speaker 1: material apart. Keep questioning the algorithms, keep learning, and we
• 39:52
  Speaker 1: encourage you to keep exploring these incredible concepts on your own.